drugset / Trial / NCT05000658

Efficacy of Soluble Dexamethasone in Refractory Sciatica

NCT05000658 ↗

Phase 3 Completed 109 enrolled Nantes University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase 3 prospective randomised double-blind study versus placebo, measuring the efficacy of soluble Dexamethasone by echo-guided infiltrations through the sacro-coccygeal hiatus in intractable sciatica

Timeline

Start
2021-12-16
Primary completion
2023-03-15
Completion
2023-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 16 mg Other

Indications